CTRI/2022/11/047794尚未招募2 期
Capecitabine- Based Chemoradiotherapy for Cisplatin ineligible Squamous Cell Carcinoma of the Uterine Cervix
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Untreated squamous cell carcinoma of cervix who are planned for definitive
- •chemoradiation
- •2. Cisplatin ineligible â?? Sensorineural hearing loss, Sensory/Motor neuropathy
- •> grade 2, Borderline renal dysfunction (Calculated creatinine clearance > 30
- •- 60ml/min), or patientâ??s unwillingness to receive cisplatin/intravenous
- •chemotherapy.
- •3. Eastern Cooperative Oncology Group performance status of 0, 1, or 2.
- •4. Adequate Aspartate transaminase (AST) and Alanine transaminase (ALT)
- •within 3 times the upper limit of normal (ULN), serum bilirubin less than 2
排除标准
- •1. Preexisting coronary heart disease (Unstable angina, Echocardiography
- •showing regional wall motion abnormalities or ejection fraction < 50 %),
- •NYHA (Newyork Heart Association) class > 2
- •2. Known dihydropyramidine dehydrogenase (DPD) mutation
- •3. Creatinine clearance < 30ml/min
- •4. Uncontrolled comorbid illness
- •5. Inflammatory bowel disease
- •6. Patient taking oral anti coagulants like warfarin
研究者
相似试验
已完成
1 期
Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist Anakinra for rectal cancer patients. A phase I trial of the German Rectal Cancer Study GroupC20Malignant neoplasm of rectumDRKS00025477niversitätsklinikum Frankfurt Goethe-Universität Frankfurt am Main12
进行中（未招募）
不适用
Radiochemotherapy in association with capecitabine and oxaliplatin in the treatment of pancreatic and biliary tract, unresectable cancer: a dose escalation study - XelOx -P07pancreatic and biliary tract, unresectable cancerMedDRA version: 9.1Level: LLTClassification code 10033611Term: Pancreatic carcinoma non-resectableEUCTR2007-004814-15-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
进行中（未招募）
不适用
Radiotherapy and chemotherapy with cisplatin and temozolomide for patients affected by primary glioblastoma of new diagnosis - NDPrimary GLIOBLASTOMA of first diagnosisMedDRA version: 9.1Level: PTClassification code 10018336MedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2008-000380-42-ITISTITUTO NEUROLOGICO CARLO BESTA
招募中
2 期
Induction chemoradiotherapy with cisplatin plus vinorelbine and irradiation, followed by surgery in cT1-3N2M0, stage IIIA non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000005416Kyoto University Hospital35
已完成
2 期
Concomitant radiotherapy and weekly cisplatin with or without prior induction chemotherapy with cisplatin, epirubicin and paclitaxel (CEP) in patients with locally advanced nasopharyngeal carcinomaocally advanced nasopharyngeal carcinomaLocally advanced nasopharyngeal carcinomaCancer - Head and neckACTRN12609000730202Hellenic Cooperative Oncology Group148